We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Extends Antitrust Review Of Barr Acquisition

Law360 (August 15, 2006, 12:00 AM EDT) -- The U.S. Federal Trade Commission has made a second request for information in its antitrust review of Barr Laboratories acquisition of European generic drug giant, Pliva.

In a conference call concerning the company’s financial status Tuesday, Barr Chief Executive Bruce Downey said that, following conversations with regulators, he’s confident the FTC will eventually allow the deal to proceed.

“We expect to rap up the FTC discussions pretty quickly,” he said.

In July, Barr submitted documents about the deal to the FTC, as well as required regulatory...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.